Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors. - Wikidata - wikimedia - TriplyDB

Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors.

Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors.

http://www.wikidata.org/entity/Q34289973

about

Screening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in China Identification of the critical sites of NNRTI-resistance in reverse transcriptase of HIV-1 CRF_BC strains HIV-1 Genetic Variability and Clinical Implications HIV-1 genetic variation and drug resistance development.Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.Are subtype differences important in HIV drug resistance?In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.Patterns of HIV-1 Drug-Resistance Mutations among Patients Failing First-Line Antiretroviral Treatment in South India.Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C Substitutions Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways.In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.Docking analysis and resistance evaluation of clinically relevant mutations associated with the HIV-1 non-nucleoside reverse transcriptase inhibitors nevirapine, efavirenz and etravirine.Human immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina Faso

P2860

Q28485108-CE08941B-8AB2-404E-8899-FEC1657F4997 Q28537991-265707DE-578D-4FFB-95B8-5DD02D106652 Q30352010-EE8EC379-F92E-44B5-8E25-310BA74B3FCB Q30354857-68CED0FE-1134-4BEB-A85B-C90F0165C102 Q34303603-C1CF4453-35DB-4B4E-8375-0EF7D5D0AE71 Q34737547-93554375-7742-44FE-AC50-F6D907736A18 Q35105844-2A51442C-A22F-4045-89A0-E9CCB884958B Q35260403-BB3C7EFC-A2B6-4831-ACB0-F18E529561D8 Q35859896-72F3BDD2-5F3E-4055-9CC2-CEA630AB9B2D Q36018893-44A36B3D-FDB8-4953-9BC9-FB30110CE16A Q36077418-AF1DD605-E829-4C2B-9825-4847F1CEC3BB Q36277181-1FBD8B81-8DD1-4A47-81D1-9DFA4282590B Q36501787-D34DF20A-5794-4024-AE18-5A6E9460D2EA Q37263490-72D0BC1F-C7FC-4355-BA39-ACA21EFE8302 Q37633109-2B3AB4BC-6D32-4A51-A554-439D15F3A103 Q37643598-05C300E4-6924-4F3C-A8F6-81525549434F Q38748311-BE2A7ACF-D73F-41E2-BF69-310DACBAEEC4 Q38962278-2268560B-EC55-4D19-BB4C-47C259E46B53 Q39350740-68A97865-EF27-462B-B7F6-1FFA32AFA551 Q39627546-8E823936-0EEC-4631-89DD-C9E1536C956C Q41668874-CAA44D4E-7A4C-431A-A887-03137A7396F8 Q41720036-4E920D57-468E-43F9-A4E8-C4EAA13C4CD3 Q46230871-FBC25DA4-F2F1-4E1C-AA13-5C86DC4930C3 Q56335908-BF0BC90A-00DD-43B0-BFEA-91FC840A193B

P2860

Distinct mutation pathways of non-subtype B HIV-1 during in vitro resistance selection with nonnucleoside reverse transcriptase inhibitors.

http://www.wikidata.org/entity/Q34289973

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@ast

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@en

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@nl

type

label

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@ast

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@en

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@nl

prefLabel

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@ast

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@en

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@nl

P1433

Q34289973-59F1B6A3-1593-45E5-A7CE-236C304FAF0E

P1476

Q34289973-9EAC1AEA-D066-4E36-A6FC-37C6E256499C

P2093

Q34289973-13FDD90A-8058-4129-83AA-253EEDC79A85

Q34289973-15E8B0AF-91BE-4DF5-BBA4-33D8FABD3982

Q34289973-2253CA7C-80FE-4220-B14E-837436FA8495

Q34289973-2CB9DC16-8FA7-42F4-8D86-6B8043744B62

Q34289973-4EE05D7A-2371-4E7D-9709-9F4FCB8BEE9E

Q34289973-5C371336-C938-461C-8EE1-AD24D8A1A9EE

Q34289973-65150115-6985-4512-A461-DA42E08B88D3

Q34289973-9559C9F9-2E5C-4C00-96F6-FC8B96A00B86

Q34289973-B2AE3F3B-BE13-4DD4-993A-F68E67EF2814

Q34289973-B7191FFD-95CE-4137-AE04-06F588A70610

P2860

Q34289973-02C4AC1D-DC0E-4B3A-BA01-CE6C70548ABF

Q34289973-0C63D378-C08E-4A5A-A56D-678A04D3F95D

Q34289973-0D0C8B7F-B35B-42CA-88C3-A7F14BAF150B

Q34289973-14FD7692-C41F-4090-8FBA-FC4617B19F98

Q34289973-1B76509A-E322-43DE-BD4E-4B55ADD59F30

Q34289973-20AF6DC7-9F5A-42D6-A188-EFF7481CCA45

Q34289973-2201F866-70A3-4758-B79E-805FDD96AA21

Q34289973-2C213D1D-A5CB-4E09-8FAB-6988EEEDFD19

Q34289973-3504B3EE-35FF-4FD9-9A33-FB98B5CF3F30

Q34289973-39995319-8869-4D1F-835B-3DB57783E9D2

P304

Q34289973-A865A041-4306-4C17-B50C-1EA003E3D329

P31

Q34289973-48AEB29D-010E-4E90-9A6E-43963775E0D8

P356

Q34289973-B2AEFAB6-BEE3-4D22-9699-6AC9A008D5CD

P407

Q34289973-9E9BD866-C63F-4441-ABE3-236207A81C7C

P433

Q34289973-45F13243-23D7-4FAE-A8E4-7C34657CD810

P478

Q34289973-FDFAAE0F-3EF1-4611-9A09-E80DF3527F5C

P577

Q34289973-E62F511B-8D3F-4996-ABD8-5C5F18D6256F

P698

Q34289973-25CED985-441E-4B84-9210-82C74243ECDF

P932

Q34289973-FCE05564-D7D9-42B1-ADCF-75E1089818FD

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Distinct mutation pathways of ...... erse transcriptase inhibitors.

@en

P2093

Daria J Hazuda

http://www.w3.org/2001/XMLSchema#string

Georgia B McGaughey

http://www.w3.org/2001/XMLSchema#string

Jay A Grobler

http://www.w3.org/2001/XMLSchema#string

Meiqing Lu

http://www.w3.org/2001/XMLSchema#string

Michael D Miller

http://www.w3.org/2001/XMLSchema#string

Ming-Tain Lai

http://www.w3.org/2001/XMLSchema#string

Peter J Felock

http://www.w3.org/2001/XMLSchema#string

Philip M McKenna

http://www.w3.org/2001/XMLSchema#string

Renee C Hrin

http://www.w3.org/2001/XMLSchema#string

Robert M Tynebor

http://www.w3.org/2001/XMLSchema#string

P2860

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors

Discovery of 3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): a potent, orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitor with improved potency against key mutant viruses

Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors

Timing the ancestor of the HIV-1 pandemic strains

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance

P304

4812-4824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00829-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20805392

http://www.w3.org/2001/XMLSchema#string

P932

2976110

http://www.w3.org/2001/XMLSchema#string